Guse Kyle bought PSTV
August 13, 2025 · Form 4 insider transaction
Guse Kyle bought 40,000 shares of Plus Therapeutics Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,000
Price
$0.00
Total value
N/A
InsiderGuse Kyle
RoleDirector
CompanyPlus Therapeutics Inc (PSTV)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateAugust 13, 2025
Filing dateAugust 15, 2025
Shares owned after40,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options vest monthly over 24 months from the Grant Date in substantially equal monthly installments.